Minnesota-based Solventum Corporation (SOLV) officially spun off from 3M to become an independent healthcare company in 2024. The company is a global healthcare innovator that blends material science, ...

Solventum Corporation SOLV is well-poised for growth in the coming quarters, driven by strong demand across its business segments, supported by continued investment in innovation, R&D and digital ...

A year ago, Solventum faced skepticism and challenges as it embarked on its journey as an independent company. Today, under CEO Bryan Hanson's leadership, the turnaround titan is proving doubters ...

Feb 26 (Reuters) - Medical device maker Solventum (SOLV.N), opens new tab on Thursday beat Wall Street estimates for the fourth quarter, helped by strong demand for its wound care and sterilization ...

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported fourth-quarter net income of $63 million. The Maplewood, Minnesota-based company said it had net income of ...

Solventum, a leader in healthcare technology and speech recognition documentation, announced its official designation as an Accelerator partner in the MEDITECH Alliance. Through this partnership, the ...

Shares of Solventum Corp. SOLV slipped 1.15% to $79.24 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.74% to 6,845.50 and ...

Analysts are changing their tune on Solventum as 2025 comes to a close, as analysts at BTIG upgrade the company to “buy” in the final month of the year. Solventum has spent the last year routinely ...

Fintel reports that on December 2, 2025, BTIG upgraded their outlook for Solventum (NYSE:SOLV) from Neutral to Buy. Analyst Price Forecast Suggests 0.63% Upside As of November 16, 2025, the average ...